NEW YORK, August 17 – GeneProt has appointed Bertrand Damour chief financial officer, Stephen Macevicz, vice president of intellectual property, and Diana Wetmore chief technical officer for the Geneva branch, the company announced on Friday.
Bertrand Damour joins the proteomics company from JP Morgan in London, where he was senior vice president and co-head of the investment banking risk management group. Prior to that, Damour worked at Deutsche Bank and Bankers Trust.
Stephen Macevicz was formerly vice president of legal affairs at Lynx Therapeutics. Prior to that, Macevicz was senior patent attorney and chief patent counsel at Applied Biosystems.
Diana Wetmore served at Anadys Pharmaceuticals, formerly Scriptgen Pharmaceuticals, as senior director of R&D project management. She also worked at DuPont Merck Pharmaceutical researching biophysical characterization of protein-ligand interactions.
GeneProt is based in Evanston, Ill.